ELVN Enliven Therapeutics, Inc.

Fundamentals / CIK 0001672619 / USD

Enliven Therapeutics, Inc. reported $897.2M in total assets and a net loss of $113.5M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ELVN in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

7 fiscal years (2019 to 2025), reported in USD.

$0$0$0-$96.95MFY 2019 Net Income: -$23.46M2019FY 2020 Net Income: -$41.36M2020FY 2021 Net Income: -$51.38M2021FY 2022 Net Income: -$37.66M2022FY 2023 Net Income: -$71.58M2023FY 2024 Net Income: -$89.02M2024FY 2025 Net Income: -$103.7M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Research & Development $85.86M $80.78M $64.57M $31.02M $38.44M $32.15M $19.01M
Total Operating Expenses $119.7M $104.6M $83.53M $38.79M $51.44M $41.70M $24.12M
Operating Income -$119.7M -$104.6M -$83.53M -$38.79M -$51.44M -$41.70M -$24.12M
EBITDA -$119.4M -$104.3M -$83.23M -$38.59M -$51.34M -$41.60M -$24.08M
Income Before Tax -- -- -- $1.58M -$51.38M -- --
Income Tax Expense $0 $232K $0 $0 -- -- --
Net Income -$103.7M -$89.02M -$71.58M -$37.66M -$51.38M -$41.36M -$23.46M
Basic EPS -$1.83 -$1.89 -$2.01 -$12.05 -$20.29 -$30.22 -$285.96
Diluted EPS -$1.83 -$1.89 -$2.01 -$12.05 -$20.29 -$30.22 -$285.96
Basic Shares Outstanding 56.7M 47.1M 35.5M 3.1M 2.5M 1.6M 82.0K
Diluted Shares Outstanding 56.7M 47.1M 35.5M 3.1M 2.5M 1.6M 82.0K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $28.02M $29.00M $20.69M $21.25M $18.23M $21.49M $24.89M $20.72M
Total Operating Expenses $36.05M $37.21M $27.82M $34.28M $25.10M $28.58M $31.69M $26.90M
Operating Income -$36.05M -$37.21M -$27.82M -$34.28M -$25.10M -$28.58M -$31.69M -$26.90M
EBITDA -$36.03M -$37.20M -$27.81M -$34.20M -$25.03M -$28.50M -$31.62M -$26.83M
Income Tax Expense -- -- -- -- $0 $0 -- --
Net Income -$27.70M -$32.48M -$23.63M -$29.67M -$20.15M -$25.34M -$28.54M -$23.18M
Basic EPS -$0.36 -$0.49 -$0.38 -- -$0.32 -$0.49 -$0.57 --
Diluted EPS -$0.36 -$0.49 -$0.38 -- -$0.32 -$0.49 -$0.57 --
Basic Shares Outstanding 78.0M 66.2M 62.8M -- 62.1M 52.1M 50.1M --
Diluted Shares Outstanding 78.0M 66.2M 62.8M -- 62.1M 52.1M 50.1M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $98.90M $124.1M $100.1M $75.54M $48.31M $47.70M $4.94M
Short-Term Investments $363.7M $189.3M $153.0M $0 $41.97M $40.52M $23.97M
Cash & Short-Term Investments $462.6M $313.4M $253.1M $75.54M $90.30M $88.20M $28.91M
Total Current Assets $474.9M $318.1M $266.2M $77.75M $92.70M $90.41M $30.62M
Property, Plant & Equipment, Net $34K $458K $742K $890K $250K $349K $442K
Long-Term Investments -- -- -- $0 -- -- --
Other Non-Current Assets $656K $7.17M $4.09M $0 $175K $88K $2.23M
Total Non-Current Assets $1.29M $7.63M $5.72M $5.54M $950K $437K $2.67M
Total Assets $476.2M $325.8M $271.9M $83.30M $93.65M $90.84M $33.30M
Accounts Payable $2.16M $1.34M $532K $3.44M $2.36M $1.97M $1.66M
Total Current Liabilities $16.57M $15.91M $25.89M $9.71M $7.21M $6.25M $4.20M
Other Non-Current Liabilities $0 $0 $67K $659K -- -- --
Total Non-Current Liabilities $0 $0 $67K $659K $406K $160K $184K
Total Liabilities $16.57M $15.91M $25.96M $10.37M $7.62M $6.41M $4.38M
Total Debt (incl. Leases) $399K -- $335K -- $652K -- --
Common Stock $59K $49K $41K $1.0K $27K $18K $1.0K
Retained Earnings -$347.2M -$243.5M -$154.4M -$82.86M -$147.5M -$96.11M -$54.75M
Accumulated Other Comp. Income $334K $55K $141K $0 -$16K $4.0K $32K
Total Stockholders' Equity $459.6M $309.8M $245.9M -$76.83M -$42.89M $84.44M -$48.85M
Total Equity $459.6M $309.8M $245.9M -$76.83M -$42.89M $84.44M -$48.85M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $151.7M $135.5M $132.2M $98.90M $101.7M $119.4M $101.7M $124.1M
Short-Term Investments $732.7M $759.6M $320.2M $363.7M $375.8M $371.1M $187.8M $189.3M
Cash & Short-Term Investments $884.4M $895.2M $452.4M $462.6M $477.6M $490.5M $289.6M $313.4M
Total Current Assets $894.8M $907.3M $463.1M $474.9M $482.7M $495.6M $294.3M $318.1M
Property, Plant & Equipment, Net $201K $140K $20K $34K $399K $462K $404K $458K
Other Non-Current Assets $962K $1.24M $1.19M $656K $7.10M $7.24M $7.20M $7.17M
Total Non-Current Assets $2.47M $2.88M $1.72M $1.29M $8.19M $8.27M $8.25M $7.63M
Total Assets $897.2M $910.2M $464.9M $476.2M $490.9M $503.9M $302.6M $325.8M
Accounts Payable $2.73M $371K $1.64M $2.16M $1.43M $2.35M $1.56M $1.34M
Total Current Liabilities $19.47M $14.16M $11.49M $16.57M $14.65M $15.21M $13.97M $15.91M
Other Non-Current Liabilities $805K $913K -- $0 $103K $204K $302K $0
Total Non-Current Liabilities $805K $913K $0 $0 $103K $204K $302K $0
Total Liabilities $20.28M $15.07M $11.49M $16.57M $14.75M $15.41M $14.27M $15.91M
Total Debt (incl. Leases) $1.31M $1.51M $302K $399K $490K $580K $667K --
Common Stock $74K $73K $61K $59K $59K $59K $49K $49K
Retained Earnings -$431.0M -$403.3M -$370.8M -$347.2M -$317.5M -$297.4M -$272.0M -$243.5M
Accumulated Other Comp. Income -$3.51M -$1.91M -$382K $334K $221K -$177K -$16K $55K
Total Stockholders' Equity $876.9M $895.1M $453.4M $459.6M $476.1M $488.5M $288.3M $309.8M
Total Equity $876.9M $895.1M $453.4M $459.6M $476.1M $488.5M $288.3M $309.8M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$103.7M -$89.02M -$71.58M -$37.66M -$51.38M -$41.36M -$23.46M
Depreciation & Amortization $300K $300K $300K $200K $99K $97K $33K
Stock-Based Compensation $34.02M $20.17M $12.91M $3.19M $3.85M $2.23M $899K
Change in Payables $817K $810K -$2.25M $411K $389K $313K $750K
Operating Cash Flow -$70.30M -$73.19M -$61.27M -$32.08M -$46.77M -$37.40M -$21.88M
Capital Expenditure -$158K -$44K -$149K -$612K -$12K -$18K -$140K
Free Cash Flow -$70.46M -$73.24M -$61.42M -$32.69M -$46.78M -$37.42M -$22.02M
Purchases of Investments -$446.8M -$350.7M -$268.3M $0 -- -- --
Investing Cash Flow -$173.8M -$36.00M -$148.4M -$612K -$1.63M -$16.72M -$24.06M
Common Stock Issued -- $0 $161.4M $0 -- -- --
Financing Cash Flow $218.9M $133.2M $234.3M -$1.80M $49.10M $96.88M $43.58M
Net Change in Cash -$25.27M $23.98M $24.61M -$34.49M $698K $42.76M -$2.36M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$27.70M -$32.48M -$23.63M -$29.67M -$20.15M -$25.34M -$28.54M -$23.18M
Depreciation & Amortization $13K $7.0K $14K $83K $62K $81K $74K $63K
Stock-Based Compensation $8.06M $13.91M $7.40M $12.31M $7.18M $7.72M $6.80M $5.34M
Change in Payables $2.59M -$1.50M -$519K $828K -$1.02M $789K $220K $323K
Operating Cash Flow -$12.55M -$18.53M -$19.29M -$15.84M -$13.28M -$17.06M -$24.13M -$17.20M
Capital Expenditure -$94K -$99K $0 $0 $1.0K -$139K -$20K $0
Free Cash Flow -$12.65M -$18.63M -$19.29M -$15.84M -$13.28M -$17.20M -$24.15M -$17.20M
Purchases of Investments -$45.97M -$560.2M -$65.84M -$75.52M -$71.86M -$240.2M -$59.23M -$116.5M
Investing Cash Flow $26.33M -$441.6M $42.53M $12.38M -$4.06M -$183.6M $1.43M $727K
Common Stock Issued -- -- -- -- -- -- -- $0
Financing Cash Flow $2.39M $463.4M $10.05M $623K -$368K $218.4M $234K $39.97M
Net Change in Cash $16.16M $3.32M $33.29M -$2.84M -$17.70M $17.73M -$22.47M $23.50M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -22.6% -28.7% -29.1% -- -- -49.0% --
Return on Assets (ROA) -21.8% -27.3% -26.3% -45.2% -54.9% -45.5% -70.5%
Current Ratio 28.66x 19.99x 10.28x 8.00x 12.86x 14.47x 7.29x
Quick Ratio 27.92x 19.69x 9.77x 7.78x 12.52x 14.12x 6.89x
Debt to Equity 0.00x -- 0.00x -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -12.9% -11.8% -21.8% -22.6% -20.4% -20.5% -32.9% -28.7%
Return on Assets (ROA) -12.6% -11.6% -21.2% -21.8% -19.8% -19.9% -31.3% -27.3%
Current Ratio 45.95x 64.07x 40.32x 28.66x 32.95x 32.58x 21.06x 19.99x
Quick Ratio 45.42x 63.22x 39.38x 27.92x 32.60x 32.25x 20.73x 19.69x
Debt to Equity 0.00x 0.00x 0.00x 0.00x 0.00x 0.00x 0.00x --
Source: SEC EDGAR CompanyFacts (CIK 0001672619) · from March 31, 2019 Data through September 30, 2026 · synced Nov 20, 2026, 05:18 UTC · Open in terminal